Cambridge Investment Research Advisors, Inc. View Ray, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$3.28 - $4.81 $32 - $48	-10 Reduced 0.02%	50,000 $173,000
Q3 2022 Oct 17, 2022	BUY	$2.66 - $3.97 $13 - $19	5 Added 0.01%	50,010 $182,000
Q1 2022 May 12, 2022	SELL	$3.45 - $5.83 $172 - $291	-50 Reduced 0.1%	50,005 $196,000
Q4 2021 Feb 03, 2022	SELL	$4.89 - $7.59 $141 - $220	-29 Reduced 0.06%	50,055 $275,000
Q3 2021 Nov 02, 2021	SELL	$5.18 - $7.41 $52,369 - $74,915	-10,110 Reduced 16.8%	50,084 $361,000
Q2 2021 Aug 10, 2021	BUY	$3.94 - $6.75 $237,164 - $406,309	60,194 New	60,194 $397,000

Others Institutions Holding VRAY

# of Institutions

Shares Held

645K

Call Options Held

50K

Put Options Held

30K

View Full List

About ViewRay, Inc.

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

More about VRAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account